Catalysts for Alembic Pharmaceuticals Inc
165 tracked
Dec 3, 2024
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
May 7, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Efudex
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Oct 18, 2023
approval
FLUOROURACIL — FDA approval
Efudex
→
Oct 3, 2023
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 3, 2023
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 3, 2023
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Sep 26, 2023
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Sep 26, 2023
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Aug 25, 2023
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Aug 25, 2023
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jul 20, 2023
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Apr 20, 2023
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Mar 3, 2023
approval
FLUOROURACIL — FDA approval
Efudex
→
Jul 27, 2022
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Jul 27, 2022
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Jul 27, 2022
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Jun 10, 2022
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
TIZANIDINE HYDROCHLORIDE
→
Jan 14, 2022
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jan 3, 2022
approval
DOXYCYCLINE HYCLATE — FDA approval
DOXYCYCLINE HYCLATE
→